GlamBud™ will identify prospective community members using metrics, available subscription lists and public relations events. Those identified will be solicited with a personal invitation for a ‘no-risk’ trial.  It is anticipated that with rich, balanced content and promotional offerings, GlamBud will activate and engage over one million aesthetics patients in the US by 2022.